SCHEMBL19081705

SCHEMBL19081705

c1ccc2cc3c(cc2c1)oc1c(-c2c4ccccc4c(-c4ccc5c(c4)oc4ccccc45)c4ccccc24)cc2oc4ccccc4c2c13

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AHR P35869 3/20 0.36
MEN1 O00255 3/20 0.35
MAPT P10636 3/20 0.35
KMT2A Q03164 3/20 0.35
KDM4E B2RXH2 2/20 0.35
HPGD P15428 2/20 0.35
ALDH1A1 P00352 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
CYP3A4 P08684 1/20 0.35
ALPI P09923 1/20 0.35
GAA P10253 1/20 0.35
PKM P14618 1/20 0.35
CASP3 P42574 1/20 0.35
RECQL P46063 1/20 0.35
BLM P54132 1/20 0.35
CASP7 P55210 1/20 0.35
CASP6 P55212 1/20 0.35
MCL1 Q07820 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ALOX5 P09917 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17945379 0.92 AHR (0.41) AHRMEN1MAPTKMT2AKDM4E
SCHEMBL19081436 0.91 ESR1 (0.39) AHRMEN1MAPTKMT2AKDM4E
SCHEMBL20205605 0.88 ALOX5 (0.39) AHRMEN1MAPTKMT2AKDM4E
SCHEMBL17945567 0.87 GPR84 (0.39) AHRMEN1MAPTKMT2AKDM4E
SCHEMBL24614644 0.86 KDM4E (0.33) AHRMEN1MAPTKMT2AKDM4E
SCHEMBL19081524 0.85 ESR1 (0.37) MEN1MAPTKMT2AKDM4EHPGD
SCHEMBL19081618 0.85 ESR1 (0.37) AHRMEN1MAPTKMT2AKDM4E
SCHEMBL19081452 0.85 L3MBTL1 (0.36) MEN1MAPTKMT2AKDM4EHPGD
SCHEMBL24451017 0.85 AHR (0.40) AHRMEN1MAPTKMT2AKDM4E
SCHEMBL24119040 0.84 MAPT (0.41) AHRMEN1MAPTKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 AHR 2453/4885MEN1 277/4885MAPT 1294/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 AHR 2453/4885MEN1 277/4885MAPT 1294/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.